BRANDY FRANKLIN: Open Payments
NPI 1568400307 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 68 payments from 21 companies in 2025. Trend: 2023 $1,364 · 2024 $1,208 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $257 |
| PFIZER INC. | 12 | $166 |
| Dexcom, Inc. | 4 | $132 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $99 |
| Astellas Pharma US Inc | 4 | $95 |
| Xeris Pharmaceuticals, Inc. | 3 | $64 |
| Lilly USA, LLC | 3 | $49 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| ABBVIE INC. | 3 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
Products named: Ozempic, Dexcom G6 Transmitter, NURTEC ODT, XIFAXAN, Veozah, Wegovy, GVOKE HYPOPEN, MOUNJARO.
Industry payments across FL — which companies pay providers there.
